check_circleStudy Completed
Hormone replacement therapy (HRT)
Bayer Identifier:
91461
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
EU CT Number:
Not Available
PK eval. of Angeliq - rel. BA/multiple PK
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
45 - 75 YearsTrial summary
Enrollment Goal
18Trial Dates
September 2005 - December 2005Phase
Phase 1Could I Receive a placebo
N/AProducts
Angeliq (E2/DRSP, BAY86-4891)Accepts Healthy Volunteer
N/AWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Bayer Pharma AG | Berlin, 13353, Germany |
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A